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Abstract: A pivotal role in guiding mesenchymal stem cell (MSC) differentiation has recently been attributed to the primary cilium. 
This solitary, non-motile microtubule-based organelle emerging from the cell surface acts as a sensorial membrane structure reflect-
ing developmental and adaptive processes associated with pathologies including human cystic kidney disease, skeletal malforma-
tions, obesity and cancer. Given that the intrinsic hypoxic adaptation of MSC remains poorly understood within ischemic tissues or 
hypoxic tumours, we questioned whether the hypoxia inducible factor-1α (HIF-1α) might be a downstream effector regulating cilium 
  maintenance. We show that murine bone marrow-derived MSC cultured under hypoxic conditions (1.2% O2) lose their primary cilia in a 
time-dependent manner. Gene silencing of HIF-1α prevented cilia loss in hypoxic cultures, and generation of MSC expressing a consti-
tutively active HIF-1α (MSC-HIF) was found to decrease primary cilium formation. A Wnt pathway-related gene expression array was 
also performed on MSC-HIF and indicated that the secreted Frizzled-related proteins (sFRP)-1, -3 and -4 were down-regulated, while 
sFRP-2 was up-regulated. Overexpression of recombinant sFRP-2 or gene silencing of sFRP-1, -3 and -4 in MSC led to primary cilium 
disruption. These results indicate a molecular signalling mechanism for the hypoxic disruption of the primary cilium in MSC involving 
an HIF-1α/sFRP axis. This mechanism contributes to our understanding of the adaptive processes possibly involved in the oncogenic 
transformation and tumour-supporting potential of MSC. Our current observations also open up the possibility for the primary cilia to 
serve as a biomarker in MSC adaptation to low oxygen tension within (patho)physiological microenvironments.
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Introduction
Most  commonly  isolated  from  the  bone  marrow, 
  mesenchymal stem cells (MSC) represent a population 
of pluripotent adult stem cells that can differentiate into 
many mesenchymal phenotypes, and that can adapt to 
low oxygen environments such as those encountered 
within  ischemic  tissues  or  hypoxic  tumours.1,2  This 
adaptive property has been exploited to study the ther-
apeutic efficacy of genetically-modified MSC.3–6
Homing of MSC to tumours was recently reported 
in a mouse model where injected human MSC could 
be found preferentially migrating to implanted human 
melanoma tumours.6 In fact, recruitment of MSC by 
experimental vascularizing tumours also resulted in the 
incorporation of MSC within the tumor architecture6,7 
which, combined with intrinsic immunomodulatory 
mechanisms, suggests that they must also respond to 
tumour-derived growth factor cues.8,9 Consequently, 
their potential contribution to tumour development 
implies that MSC must metabolically adapt to the 
low  oxygen  environment  and  nutrient  deprivation 
that  characterizes  hypoxic  tumours.  Moreover,  the 
sum of this evidence, in line with their increased abil-
ity to migrate under an atmosphere of low oxygen,10 
suggests that MSC may be active participants in the 
development of hypoxic solid tumours.
In order to survive within the stressful hypoxic 
microenvironment,  cells  have  developed  a  coordi-
nated set of responses orchestrating their adaptation 
to hypoxia. In cancer cells, the resultant of such cel-
lular responses to hypoxia is often associated with 
aggressive disease and resistance to therapy.11 A criti-
cal mediator of the hypoxic response is the transcrip-
tion factor hypoxia inducible factor 1 (HIF-1) which 
upregulates  expression  of  proteins  that  promote 
angiogenesis, anaerobic metabolism, and many other 
survival pathways.12 Regulation of HIF-1α, a com-
ponent of the HIF-1 heterodimer, occurs at multiple 
levels  including  translation,  degradation,  and  tran-
scriptional activation, and serves as a testimony to the 
central role of HIF-1. More recently, the canonical 
Wnt pathway was shown to be activated in stem cells 
under low oxygen culture conditions via   HIF-1α.13 
How such HIF/Wnt signalling affects the MSC adap-
tive mechanisms remains poorly documented.
Stem  cell  differentiation  and  proliferation  are 
among  the  important  processes  regulated  through 
the  Wnt  pathway.  Its  activation  in  hematopoietic 
stem cells and in MSC enhances cell proliferation, 
maintains  pluripotency  and  prevents  induction  of 
apoptosis.14–16  Moreover,  expression  of  Dickkopf 
(DKK), a Wnt inhibitor, prevented osteogenic differ-
entiation of cultured human MSC.17 Among the Wnt 
molecular  players,  secreted  Wnt  antagonists  were 
also found to be important in stem cell homeostasis in 
an in vivo gastro-intestinal cancer model.18 Autocrine 
Wnt signaling also operates in MSC populations to 
regulate mesenchymal lineage specification.19,20 The 
molecular  mechanisms  that  regulate  self-renewal, 
lineage-specific differentiation and/or adaptation still 
remain to be linked to specific biomarker expression.
The primary cilium is a sensory membrane struc-
ture which transduces surrounding mechanical and 
chemical signals and which serves as a control center 
for many protein signalling complexes.21 Despite its 
purpose in development where a role in guiding lin-
eage commitment was reported,22 the primary cilium 
mainly serves as a cell surface biomarker associated 
with  a  growing  number  of  pathologies,  including 
human cystic kidney disease, skeletal malformations, 
obesity and cancer.23 Recent evidence links the tumour 
suppressor pVHL, a protein involved in the nuclear 
translocation of HIF-1α, to cilium integrity mainte-
nance in cystic kidney disease.24 We therefore exam-
ined the biomarker potential of the primary   cilium, as 
well as the impact of Wnt signalling in MSC adapta-
tion to hypoxic cues.
experimental procedures
Materials
Sodium  dodecylsulfate  (SDS)  and  bovine  serum 
  albumin  (BSA)  were  purchased  from  Sigma 
(Oakville, ON). Cell culture media was obtained from 
  Invitrogen (Burlington, ON). All other reagents were 
from   Sigma-Aldrich Canada.
cell culture and experimental  
hypoxic conditions
Bone marrow-derived MSC were isolated from the 
whole  femur  and  tibia  bone  marrow  of  C57BL/6 
female mice; cells were cultured and characterized 
as previously described.25 Analysis by flow cytom-
etry, performed at passage 14, revealed that MSC 
expressed CD44 yet were negative for CD45, CD31, 
KDR/flk1  (VEGF-R2),  flt-4  (VEGF-R3)  and  Tie2 
(angiopoietin receptor) (data not shown). Hypoxic sFrP regulate ciliogenesis in hypoxic MSc
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culture  conditions  were  attained  by  incubation  of 
65%–80% confluent cells in an anaerobic box. The 
oxygen  was  maintained  at  1%,  as  described  by 
others,26–28  using  a  compact  gas  oxygen  controller 
Proox model 110 (Reming Bioinstruments Co., Red-
field, NY) with a residual gas mixture composed of 
94% N2 and 5% CO2.
cDnA construct generation  
and transduction of the MSc-hIF-1α
The  human  full-length  HIF-1α  cDNA  construct 
was generously provided by Dr Gregg L. Semenza 
(Johns Hopkins University, Baltimore, MD, USA), 
and was used as a template for generating an HIF-1α 
mutant which lacked its oxygen-dependent degra-
dation  domain  (ODD401–603).  The  deletion  mutant 
(HIF-1α ∆ODD) was constructed by overlap exten-
sion  using  PCR.  The  deletion  was  confirmed  by 
DNA   sequencing, and the 1.95 kb HIF-1α ∆ODD 
cDNA  was  subcloned  into  pcDNA3.1.  For  gen-
eration of retroviral particles, the HIF-1α ∆ODD 
construct was digested out of the pcDNA3.1 vec-
tor  using  BamHI  and  HpaI  restriction  enzymes 
and subcloned into the multiple cloning site of the 
bicistronic retrovector pIRES-GFP. 293-GP2 viral 
packaging  cells  were  transfected  with  either  the 
HIF-1α  ∆ODD-pIRES-GFP  or    null-pIRES-GFP 
plasmids and the viral supernant was collected at 
48 and 72 hours post-transfection. MSC were sub-
jected to 8 rounds of viral transduction. Following 
viral  transduction  each  GFP(+)MSC  (AP2-MSC) 
and HIF-1α-∆ODD-GFP(+) MSC population were 
each subjected to high speed cell sorting using a 
BD FacsAria flow cytometer to obtain polyclonal 
pooled clones of retrovirally-transfected MSC that 
were 100% GFP(+) and similar in regards to GFP 
signal intensity.
Total rnA isolation, cDnA synthesis  
and real-time quantitative rT-Pcr
Total  RNA  was  extracted  from  cell  monolayers 
using TriZol reagent (Invitrogen). For cDNA syn-
thesis, 2 µg of total RNA were reverse-transcribed 
into cDNA using a high capacity cDNA reverse tran-
scription kit (Applied Biosystems, Foster City, CA). 
cDNA was stored at −80 °C prior to PCR. Gene 
expression was quantified by real-time quantitative 
PCR  using  iQ  SYBR  Green  Supermix  (  Bio-Rad, 
Hercules,  CA).  DNA  amplification  was  carried 
out using an iCycler iQ5 (Bio-Rad, Hercules, CA) 
and product detection was performed by measur-
ing   binding of the   fluorescent dye SYBR Green I 
to  double-stranded  DNA. The  QuantiTect  primer 
sets  were  provided  by  Qiagen  (Valencia,  CA): 
sFRP-1, -2, -3, -4 (Mm_Sfrp1_1_SG QT00167153, 
Mm_Sfrp2_1_SG  QT00101759,  Mm_Frzb_1_SG 
QT00169232,  Mm_Sfrp4_1_SG  QT00120491) 
and  β-actin  (Hs_Actb_2_SG  QT01680476).  The 
relative quantities of target gene mRNA against the 
internal control β-actin RNA were measured by fol-
lowing a ∆CT method employing an amplification 
plot (fluorescence signal vs. cycle number). The dif-
ference (∆CT) between the mean values in the trip-
licate samples of target gene and those of β-actin 
mRNAs  were  calculated  by  iQ5  Optical  System 
Software version 2.0 (Bio-Rad,   Hercules, CA) and 
the relative quantified value (RQV) was expressed 
as 2−∆C
T.
Mouse Wnt signaling pathway  
Pcr array
The  Mouse  Wnt  Signaling  Pathway  RT²    Profiler 
PCR  Arrays  (PAMM-043,  SA  Biosciences, 
  Frederick, MD) were used according to the man-
ufacturer’s  protocol.  Quantitative  RT-PCR  was 
performed  and  relative  gene  expressions  were 
calculated  using  the  2−∆∆Ct  method,  in  which  Ct 
indicates  the  fractional  cycle  number  where  the 
fluorescent signal reaches detection threshold. The 
‘delta–delta’ method uses the normalized ∆Ct value 
of  each  sample,  calculated  using  a  total  of  five 
endogenous control genes (B2M, HPRT1, RPL13A, 
GAPDH, and ACTB). Fold change values are then 
presented as average fold change = 2 (average∆∆Ct) 
for  genes  in  MSC-HIF  relative  to  control  MSC. 
Detectable PCR products were obtained and defined 
as requiring ,35 cycles. Using real-time PCR, we 
reliably  analyzed  expression  of  a  focused  panel 
of genes related to Wnt-mediated signal transduc-
tion with these arrays. The resulting raw data were 
then analyzed using the PCR Array Data Analysis 
Template  (http://www.sabiosciences.com/pcrar-
raydataanalysis.php).  This  integrated  web-based 
software package automatically performs all ∆∆Ct 
based fold-change calculations from our uploaded 
raw threshold cycle data.Proulx-Bonneau and Annabi
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Immunofluorescent microscopy
Cells were seeded on 1.5-mm thick glass coverslips 
in  6-well  culture  plates.  After  hypoxic  treatment, 
media were removed and cells fixed in 10%   formalin 
phosphate  buffer  (Fisher  Scientific,  Ottawa,  ON) 
for  20  min,  permeabilized  in  0.5%  Triton  X-100/
PBS for 5 min, then blocked 1 h in 1% BSA/PBS. 
  Immunostaining was performed for 1 h with a mono-
clonal anti-acetylated tubulin antibody (clone 6-11B-1) 
1:200 in 1% BSA/PBS (Sigma, St-Louis, MO), fol-
lowed  by  1:200  anti-mouse-RedX  (Invitrogen). 
Nuclei were stained using 5 µg/mL DAPI and then 
glass coverslips were mounted on slides using Pro-
Long Gold Antifade reagent (Invitrogen, ON) before 
fluorescence was examined by microscopy, using a 
Nikon Eclipse TE2000-U microscope coupled to a 
QImaging Retiga 1300 camera.
Transfection method and rnA  
interference
Cells were transiently transfected with 20 nM siRNA 
(Qiagen)  against  HIF-1α  (Mm_Hif1a_2  Flexitube 
siRNA,  SI00193018),  sFRP-1,  -2,  -3,  -4  (Mm_
Sfrp1_1  SI01415855,  Mm_Sfrp2_1  SI00182567, 
Mm_Frzb_1 SI01005991, Mm_Sfrp4_1 SI00209818) 
or scrambled sequences (AllStar Negative Control 
siRNA, 1027281) using Lipofectamine 2000 (Invit-
rogen, ON). Specific gene knockdown was evaluated 
by qRT-PCR as described above. Small interfering 
RNA and mismatch siRNA were synthesized by Qia-
gen and annealed to form duplexes.
Morphological analysis of apoptotic  
and necrotic cells
To visualize nuclear morphology and chromatin con-
densation  by  fluorescence  microscopy,  cells  were 
stained with 0.06 mg/mL Hoechst (33258, blue fluo-
rescence) for apoptotic cells or with 50 µg/mL pro-
pidium iodide (red fluorescence) for necrotic cells.25
Statistical data analysis
Data are representative of three or more independent 
experiments.  Statistical  significance  was  assessed 
using  Student’s  unpaired  t-test.  Probability  values 
were considered significant when an asterisk identi-
fies such significance in the figures. * = P , 0.05; 
** = P , 0.01; and *** = P , 0.001.
Results
The primary cilium is expressed in MSc 
and hypoxic culture conditions diminish 
ciliogenesis
We  first  wished  to  monitor  whether  any  primary 
cilia  were  expressed  in  MSC.  MSC  were  seeded 
into petri dishes and cultured under normoxic con-
ditions.    Immunofluorescent  staining  was  perfomed 
as described in the Methods section with the anti-
  acetylated tubulin antibody. We found that approxi-
mately 70% of the cells expressed a single plasma 
membrane  protrusion  attributable  to  the  primary 
cilium (Fig. 1A). When MSC were cultured under 
hypoxic conditions for 24 and 48 hours, ciliogenesis 
was time-dependently and significantly decreased in 
hypoxic MSC cultures (Fig. 1B, closed circles) when 
compared to normoxic MSC cultures (Fig. 1B, open 
circles). Hoechst-33258 and propidium iodide stain-
ing only revealed basal levels of respective apoptotic 
and necrotic cells (,10%, data not shown) in accor-
dance  to  previous  studies,25  and  suggests  that  the 
effects observed were not due to hypoxia-increased 
cell death. Significant decrease in ciliogenesis was 
also  observed  at  48  hours  under  normoxic  culture 
conditions and may, although speculative, be attribut-
able to low nutrient supply.   Collectively, these obser-
vations still confirm that MSC express the primary 
cilium and support some hypoxia-mediated signal-
ling events that would regulate such expression.
hypoxia inducible factor-1α expression 
is crucial in the hypoxic downregulation 
of ciliogenesis
In order to assess the impact of the hypoxia inducible 
factor-1α (HIF-1α) in the hypoxia-mediated decrease 
in MSC ciliogenesis, MSC were transiently transfected 
with a scrambled siRNA sequence (Fig. 2A, upper pan-
els; Mock) or with an siRNA designed to downregulate 
HIF-1α (Fig. 2A, lower panels; siHIF-1α) as described 
in the Methods section, then put in culture under nor-
moxic (white bars) or hypoxic (black bars) conditions 
for  24  hours.  Typical  knockdown  in  HIF-1α  gene 
expression was over 80% (not shown) and in accor-
dance with our previous studies.29 Cilium staining was 
performed for each experimental condition and cilia 
were decreased, in agreement with the data in Figure 1, 
in hypoxic Mock-transfected cells (Fig. 2B, black bars). sFrP regulate ciliogenesis in hypoxic MSc
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This decrease in cilium expression in hypoxic MSC was 
prevented  from  diminishing  in  siHIF-1α-transfected 
cells (Fig. 2B, black bars). These observations prompt 
for a crucial involvement of HIF-1α-mediated regula-
tion of MSC ciliogenesis.
hIF-1α stable expression dowregulates 
ciliogenesis
In order to rule out the sole effect of hypoxia and to 
firmly establish the direct HIF-1α’s impact on MSC 
ciliogenesis, cells were engineered to stably express 
a ∆ODD HIF-1α mutant (MSC-HIF) as described in 
the Methods section. MSC and MSC-HIF were then 
cultured under normoxic conditions for 24 hours and 
cilia staining was performed (Fig. 3A). Cilium   staining 
quantification confirmed the significant decrease in 
primary cilia expression in the MSC-HIF, therefore 
establishing HIF-1α as a major molecular actor in 
cilia downregulation.
gene array analysis reveals  
involvement of members from the 
secreted frizzled-related proteins  
in the hypoxic adaptation of MSc 
Given  that  the  Wnt  signalling  pathway  has  been 
reported to regulate ciliogenesis,30,31 we performed 
a Wnt pathway-related gene expression array. Total 
RNA was isolated from MSC and from MSC-HIF, 
and  cDNA  was  synthesized  as  described  in  the 
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Figure 1. hypoxic culture conditions diminish ciliogenesis in MSc. Mesenchymal stem cells (MSc) were cultured under normoxic or hypoxic conditions 
as described in the Methods section for 24 and 48 hours. (A) Cells were fixed and cilia staining was performed. (B) Quantification of ciliogenesis in MSC 
cultured under normoxic (open circles) or hypoxic (black circles) conditions. Data are representative of three independent experiments. Three independent 
fields were quantified per experiment. Probability values of less than 0.05 were considered significant in hypoxic cultures, and an asterisk (*) identifies such 
significance relative to the normoxic culture condition.Proulx-Bonneau and Annabi
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  Methods section. A schematic   representation of the 
genes which were up-regulated and downregulated 
(threshold  in  dotted  lines)  is  depicted  (Fig.  4A). 
A value between −3.00 and 3.00 was considered not 
significant. While most of the Wnt family gene mem-
bers were unaffected (Wnt-1 to -16; Fig. 4B), Wnt-9a 
gene   expression was the only one to be upregulated 
in MSC-HIF. Interestingly, gene expression of four 
members  of  the  secreted  Frizzled-related  proteins 
(sFRP) were found modulated. While sFRP-2 was 
upregulated, the expression of sFRP-1, -3, and -4 was 
significantly downregulated (Fig. 4B).   Collectively, 
these observations prompted us to explore whether 
sFRP  transcriptional  regulation  may  effectively 
occur within MSC.
sFrP family members possess putative 
hypoxia responsive elements within their 
promoter region and are downregulated 
in hypoxic MSc
We next needed to validate the gene expression array 
data obtained previously. The data from Figure 4B 
were first used to generate a representative histogram 
of the sFRP-1, -3, and -4 gene down-regulation and 
of the sFRP-2 gene up-regulation (Fig. 5A). Specific 
involvement of HIF-1α in directing sFRP-1 to -4 gene 
regulation was next explored through sequence pro-
moter analysis. 9,000 bp sequences upstream of the 
ATG coding sequence of the murine sFRP-1, -2, -3, 
and -4 gene promoter sequences was analyzed for 
HIF putative transcription factor binding sites with 
PROMO 3.0 (http://alggen.lsi.upc.es/) using version 
8.3 of the TRANSFAC database. Several core con-
sensus sequences of the hypoxia responsive elements 
(HRE) (A_G)CGT(G_C)C were found in the murine 
sFRP  sequences  analyzed  (Fig.  5B).  Quantitative 
qRT-PCR validation of the sFRP gene expression lev-
els was finally performed in order to validate the gene 
array data and confirmed those gene expression data 
characterizing sFRP   levels in MSC-HIF compared to 
MSC (Fig. 5C).
Overexpression of sFrP-2 or gene 
silencing of sFrP-1, -3, -4 family 
members dowregulates ciliogenesis
We next proceeded to validate the gene expression 
array significance of sFRP-2 gene upregulation and 
of sFRP-1, -3, and -4 gene dowregulation in MSC-
HIF. We performed transient gene silencing of all 
sFRP  members  (Fig.  6A),  and  transiently  trans-
fected sFRP-2 cDNA (Fig. 6B) in MSC. We next 
went  on  to  immunostain  and  assess  the  primary 
cilium expression in each of these conditions. We 
found that overexpression of recombinant sFRP-2 
led  to  a  significant  decrease  in  transfected  MSC 
(Fig. 6C). In parallel experiments, gene silencing 
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Figure 2. hypoxia inducible factor-1α expression is crucial in the hypoxic 
downregulation of ciliogenesis. MSc were transiently transfected with a 
scrambled sirnA sequence (Mock) or an sirnA designed to downregu-
late hIF-1α (sihIF-1α) as described in the Methods section. (A) cells 
were  then  cultured  either  under  normoxic  or  hypoxic  conditions  for 
24 hours and cilia staining was performed. (B) Quantification of ciliogen-
esis in MSc cultured under normoxic (open bars) or hypoxic (black bars) 
conditions. Data are representative of three independent experiments. 
Probability values of less than 0.05 were considered significant, and an 
asterisk (*) identifies such significance relative to the respective control 
treatment.sFrP regulate ciliogenesis in hypoxic MSc
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of sFRP-1, -3, or -4 led to decreased ciliogenesis, 
while that of sFRP-2 did not change primary cilium 
expression (Fig. 6D).
Discussion
Hypoxia is thought to be a tissue-specific condition that 
could promote oncogenic processes. In this study we 
have demonstrated that hypoxia significantly impacts 
ciliogenesis via a HIF-1α/Wnt signalling axis. While 
the Wnt family of proteins is known to influence the 
MSC  phenotype  through  both  canonical  and  non-
  canonical  signalling  pathways,20,32  our  data  support 
the importance of the Wnt pathway in the maintenance 
of  cilium  integrity. Accordingly,  we  also  identified 
the crucial joint action of several sFRP members on 
MSC ciliogenesis. Our current   observations also open 
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up the possibility for the primary cilia to serve as a 
biomarker for MSC adaptation to low oxygen tension 
within (patho)physiological microenvironments.
The  complex  nature  of  the  hypoxic  tumor 
microenvironment  may  result  in  pro-oncogenic 
conditions  for  MSC.  As  such,  mobilization  and 
migration of MSC to the peripheral blood,33 and to 
tumors34,35 in response to hypoxic cues have recently 
been   evidenced. These events are in part explained 
by the fact that hypoxic cancer cells secrete vari-
ous  cytokines  including  IL-6,  VEGF,  PDGF  and 
FGF,  that  attract  and  promote  MSC  proliferation 
and differentiation into tumor-supporting cells.36,37 
Recently, chemosensory response to PDGF-AA in 
fibroblasts was shown to require the primary   cilium.38 
In contrast, in the bone marrow, the hypoxic niche is 
important for maintaining stemness, cell cycle, cell 
survival and metabolism of MSC and HSC.39 The 
function of MSC in tumors is likely to parallel the 
role of MSC in wound healing.40,41   Accordingly, MSC 
derived from bone marrow are thought to endog-
enously support wound healing and hematopoiesis, 
but many of their native functions under hypoxic 
conditions  remain  poorly  understood.  Under  such 
  conditions the low oxygen tension is believed to pro-
tect the genomic integrity of stem cell   populations by 
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  limiting the   production of   reactive oxygen   species 
by   mitochondrial respiration.42
Primary cilium identification as a biomarker may 
allow efficient monitoring of hypoxic MSC adaptation 
processes and help increase our understanding of the 
mechanisms involved in their oncogenic regulation. 
In combination with other MSC cell surface markers, 
hypoxic disruption of the primary cilium may also 
represent a usefull marker for clinical purposes. In 
support of this, the recent discovery of the importance 
of primary cilia in a variety of cell functions raises 
the possibility that this structure may indeed have a 
role in a variety of cancers. Recently, the formation 
of the primary cilium was disrupted in cells derived 
from astrocytoma/glioblastoma tumors.43 This obser-
vation is among the first evidence that altered pri-
mary  cilium  expression  and  function  may  be  part 
of some malignant phenotypes.44,45 MSC were also 
shown to integrate, engraft and differentiate within 
hypoxic brain tumors,46 which further highlights the 
fact that the primary cilia could serve as a diagnostic 
tool and provide new insights into the mechanism of 
tumorigenesis.
Whether  MSC  are  pro-  or  anti-tumorigenic  is 
a  subject  of  controversial  reports  that  is  in  part 
explained  by  the  complexity  of  their  homing, 
engraftment, and differentiation mechanisms within 
the tumor microenvironement.47 The differentiation 
of  MSC  into  lineage-specific  cells  is  controlled 
by external factors in the environment, including 
cell–cell  and  cell–ECM  adhesion  and  cytokine, 
chemokine,  and  growth    factor  availability.48,49 
  Several  signalling  pathways  have  recently  been 
identified in MSC proliferation and differentiation 
control including canonical and non-canonical Wnt, 
RhoA/ROK, and Erk.50–52 Our current study high-
lights  the  increased  levels  of  sFRP-2  in  hypoxic 
MSC. Accordingly, while sFRP-1 and sFRP-2 are 
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produced by the   majority of   longterm and ex vivo 
malignant  glioma  cell  lines,  only  sFRP-2  was 
shown to strongly   promote the growth of intrac-
ranial glioma xenografts in nude mice.53 We also 
report that sFRP-1, -3, and -4 downregulation cor-
relates with the hypoxic MSC phenotype that leads 
to decreased   ciliogenesis. Intracellular Wnt effec-
tors, such as Fuzzy and Inturned, were found to 
disrupt the primary cilium structure in Drosophila 
melanogaster  embryos.54  Interestingly,  sFRP-1  is 
frequently silenced in many types of cancer leading 
to aberrant activation of Wnt signaling.55 Given they 
all possess HRE in their promoter region, it remains 
to be clarified how different sFRPs may have oppos-
ing effects on the same process and how they affect 
cell cycle progression and/or cell differentiation.56 
Of note, primary cilia are coupled to the cell cycle 
and, in vertebrates, cilia believed to only present 
on non-proliferating cells, and resorbed during cell 
cycle progression to release the centrosome from 
the ciliary basal body, which makes it available for 
duplication and organization of the mitotic spindle.
Our current observations may also impact on the 
potential of MSC to promote tissue repair in a diverse 
array  of  diseases,  including  ischemic  heart  disease, 
diabetes, and Parkinson’s disease.57 When engrafted at 
sites of tissue injury, MSC differentiate into connective 
tissue elements, support vasculogenesis, and secrete 
cytokines and growth factors that facilitate healing. 
Accordingly, MSC were confirmed as promising tools 
for cell therapy, as proven effective in US FDA-approved 
clinical trials for myocardial infarction, stroke, meniscus 
injury,  limb  ischemia,    graft-versus-host  disease  and 
autoimmune disorders.58 The hypoxia/ischemia alter-
ation  of  MSC  within  these  pathological  states  still 
remains  poorly  understood.  Clinical  trials  for  MSC 
injection into the CNS to treat traumatic brain injury 
and stroke are also ongoing. One may envision that 
ischemic/hypoxic regulation of primary cilium expres-
sion may help monitor intravenous infusion of MSC 
to in vivo cerebral ischemia tissues.59 Neuroprotective, 
trophic support and therapeutic efficacy through MSC 
mobilization was also demonstrated in several isch-
emia/reperfusion models.60–62 In conclusion, our study 
enabled us to identify secreted Wnt-related proteins 
that contribute to hypoxic regulation of ciliogenesis in 
MSC. A schematic summary of the hypoxia-mediated 
regulation  of  ciliogenesis  in  MSC  under  (patho) 
physiological  conditions  is  provided  (Fig.  7). Alto-
gether, we also provide new insight into stem cells 
biology and stem cell adaptation to hypoxia.
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